Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 2013. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific director transaction and contains no financial performance data.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely details a change in shareholding interest for a specific director.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It is a compliance notification regarding a charitable gift of shares.
Important Facts for Investors
- Director Transaction: Sir Andrew Witty, a Director of GlaxoSmithKline plc, disposed of 7,174 Ordinary Shares.
- Transaction Type: The disposal was made by way of a charitable gift.
- Transaction Date: The transaction occurred on November 28, 2013.
- Notification Date: The Company and the Director were advised of the transaction on November 29, 2013.
- Regulatory Basis: The notification complies with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.